ConvaTec Group PLC Director/PDMR Shareholding (3442N)
19 Maggio 2020 - 11:40AM
UK Regulatory
TIDMCTEC
RNS Number : 3442N
ConvaTec Group PLC
19 May 2020
19 May 2020
ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding
The Company has been notified of the following transaction by a
Person Discharging Managerial Responsibility ("PDMR") in ordinary
shares of 10 pence each in the share capital of the Company
("Shares").
On 14 May 2020, Mr Rick Anderson, Non-Executive Director and a
PDMR, acquired 1,322 Shares at GBP1.7972 per share under the Scrip
Dividend Scheme. Mr Anderson's resulting shareholding is 208,590
Shares.
The attached notification, made in accordance with the
requirements of the EU Market Abuse Regulation, gives further
detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Rick Anderson
2 Reason for the notification
a) Position/Status Non-Executive Director
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name ConvaTec Group Plc
b) LEI 213800LS272L4FIDOH92
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the financial Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")
instrument, type of instrument GB00BD3VFW73
Identification code
b) Nature of the transaction Acquisition of Shares under Scrip Dividend Scheme
c) Price(s) and volume(s) Price(s) Volume(s)
GBP1.7972 1,322
d) Aggregated information
- Aggregated volume N/A
- Price N/A
e) Date of the transaction 14 May 2020
f) Place of the transaction Outside a trading venue
Enquiries
Analysts and Investors
Mark Reynolds, Director Investor Relations, ConvaTec +44 (0)7551
036 625
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane / Vicky Hayns +44 (0)207
466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions. The
Company is listed on the London Stock Exchange (stock symbol: CTEC)
and has established market positions in advanced wound care, ostomy
care, continence and critical care, and infusion care. ConvaTec's
products provide a range of clinical and economic benefits,
including infection prevention, protection of at-risk skin,
improved patient outcomes and reduced total cost of care. Further
information can be found at www.convatecgroup.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFIFVAELIALII
(END) Dow Jones Newswires
May 19, 2020 05:40 ET (09:40 GMT)
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Apr 2023 a Apr 2024